Esperion Therapeutics
ESPR
#6123
Rank
C$1.25 B
Marketcap
C$5.30
Share price
-2.05%
Change (1 day)
-2.17%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2025 (TTM): C-$0.76

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is C-$0.75. In 2024 the company made an earnings per share (EPS) of C-$0.32 an increase over its 2023 EPS that were of C-$2.93.

EPS history for Esperion Therapeutics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$0.76140.13%
2024C-$0.32-89.15%
2023C-$2.93-40.28%
2022C-$4.91-62.87%
2021C-$13.2380.38%
2020C-$7.3450.14%
2019C-$4.89-53.18%
2018C-$10.447.41%
2017C-$9.72110.81%
2016C-$4.6147.35%
2015C-$3.130.89%
2014C-$3.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ultragenyx Pharmaceutical
RARE
C-$8.22 1,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$3.76-603.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$2.38-418.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$60.13-8,144.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C-$0.15-79.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
C-$0.26-64.81%๐Ÿ‡บ๐Ÿ‡ธ USA